Indo Borax Q1FY27 Profit Surges 59% to ₹16.25 Crore on Strong Demand
Indo Borax & Chemicals Ltd. reported a 59.31% consolidated net profit surge to ₹16.25 crore for Q1FY27, up from ₹10.20 crore in Q1FY26. Operating income grew 31.34% to ₹70.36 crore. The company's Board approved the amalgamation of its subsidiary, Indoborax Infrastructure Private Ltd., with Indo Borax Chemicals, pending regulatory approvals.
The substantial increase in profit and revenue, coupled with the strategic amalgamation of a subsidiary, indicates a significant positive development for the company's future performance and operational structure.
The company reported strong financial results with significant growth in net profit and operating income, along with improved margins. The approved amalgamation of a subsidiary is also a positive strategic development.
Indo Borax & Chemicals Ltd. reported a significant surge in its net profit for the quarter ended June 30, 2026, with a consolidated profit of ₹16.25 crore, marking a 59.31% increase compared to ₹10.20 crore in the same period last year. This growth was driven by robust demand in the boron-based chemicals market and improved operational efficiencies. The company's operating income on a consolidated basis also saw a substantial rise of 31.34%, reaching ₹70.36 crore from ₹53.57 crore in the corresponding quarter of the previous year.
EBITDA for the quarter was reported at ₹19.80 crore, a significant jump from ₹12.21 crore in Q1FY26. The company's EBITDA margin improved by 530 basis points to 28.1%, and the PAT margin increased by 430 basis points to 22.3%, indicating enhanced profitability. Earnings per share (EPS) grew by 59.43% to ₹5.07 from ₹3.18.
In a strategic move, the company's Board has approved the amalgamation of its wholly-owned subsidiary, Indoborax Infrastructure Private Ltd., with Indo Borax Chemicals. This amalgamation is subject to necessary approvals from the National Company Law Tribunal (NCLT) and other regulatory authorities. Mr. Suresh Katra, Managing Director & CEO, expressed optimism about the market, stating that the boron-based chemicals market is witnessing robust demand across various sectors. He added that the company's advanced manufacturing capabilities and improved operational efficiency position it well to sustain this growth momentum.
What to do with a filing like this
Indo Borax & Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indo Borax & Chemicals Limited. Read the original for the full detail.